Antibiotic effectiveness: balancing conservation against innovation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25214620.
- Also identified by DOI 10.1126/science.1254163.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antibiotic effectiveness is a natural societal resource that is diminished by antibiotic use. As with other such assets, keeping it available requires both conservation and innovation. Conservation encompasses making the best use of current antibiotic effectiveness by reducing demand through vaccination, infection control, diagnostics, public education, incentives for clinicians to prescribe fewer antibiotics, and restrictions on access to newer, last-resort antibiotics. Innovation includes improving the efficacy of current drugs and replenishing effectiveness by developing new drugs. In this paper, I assess the relative benefits and costs of these two approaches to maintaining our ability to treat infections.
Medical subject headings
- Anti-Bacterial Agents
- Communicable Disease Control
- Communicable Diseases
- Drug Resistance, Bacterial